Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Outside Lovers' Decision: Favored Climbing Rucksacks - 2Make your choice for a definitive Christmas getaway destination!
- 35 Great High-Mileage Electric Vehicles Of 2024
- 4IDF says up to 90% of Iran’s weapons industry could be hit within days
- 5From Representative to Business visionary: Private issue Victories
- 6 Savvy Locks for Lofts
- Vote in favor of the wide open action that revives your brain and soul!
- New India programme supports tribal families hosting tourists
- Anthony Joshua's driver charged over Nigeria crash that killed two
- Woman charged in unprovoked stabbing of tourist changing baby's diaper in Macy’s Herald Square store
- Manual for Tracking down the Mysterious Cascades in China
- This St Nick Truly Can Advise How To Drink And Hack Your Headache
- How to watch NASA's Artemis 2 astronauts launch to the moon on April 1
- 2025 among world's three hottest years on record, WMO says
